The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review
Authors:
- 1 November 2015
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (11) , 2028-2033
Abstract
Background Around 10% of all thrombotic cerebrovascular events (CVE) occur in young population and in a large proportion of those the trigger remains undetermined. Antiphospholipid antibodies (aPL) are recognised risk factors for ischaemic stroke and recurrent thrombotic events; however, the frequency of aPL in young people with CVE is still an unresolved issue. Objectives To estimate the frequency of aPL in young adults with CVE and to determine whether aPL-positive young individuals are at greater risk of CVE when compared with individuals without aPL by systematically reviewing the literature. Methods Medline reports published between 1970 and 2013 investigating the presence of aPL in young patients (Findings This systematic review is based on available data from 5217 patients and controls from 43 studies analysing the frequency of aPL in young patients with CVE. The overall aPL frequency was estimated as 17.4% (range 5%–56%) for any CVE, 17.2% (range 2%–56%) for stroke and 11.7% (range 2%–45%) for transient ischaemic attack (TIA). The presence of aPL increased the risk for CVE by 5.48-fold (95% CI 4.42 to 6.79). Based on available data, the frequency of aPL in young patients with CVE can be estimated at 17%, rising up to 22% for aCL in patients with stroke. The presence of aPL seems to confer a fivefold higher risk for stroke or TIA when compared with controls. However, variability in test reproducibility and cut-off definition still represent an important methodological limitation for the current diagnostic testing for aPL. These observations should be confirmed by appropriately designed population studies.Keywords
This publication has 47 references indexed in Scilit:
- Canadian Pregnancy Outcomes in Rheumatoid Arthritis and Systemic Lupus ErythematosusInternational Journal of Rheumatology, 2011
- Risk Scale for the diagnosis of antiphospholipid syndromeAnnals of the Rheumatic Diseases, 2011
- Risk factors for ischemic stroke and transient ischemic attack in patients under age 50Journal of Thrombosis and Thrombolysis, 2010
- Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2010
- Young strokes in Sri Lanka: An unsolved problemJournal of Stroke and Cerebrovascular Diseases, 2009
- β 2 -Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial InfarctionStroke, 2001
- Prothrombotic states in young people with idiopathic stroke. A prospective study.Stroke, 1994
- Lupus anticoagulant and the fibrinolytic system in young patients with stroke.Stroke, 1993
- Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia.Stroke, 1992
- Etiology, prognosis, and hemostatic function after cerebral infarction in young adults.Stroke, 1989